B-Cell Neoplasm — Trials

B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 2,851–2,883 of 2,883 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00063713	VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma	completed	Phase 2	152	Millennium Pharmaceuticals, Inc.INDUSTRY	1	Feb 11, 2008	clinicaltrials
NCT00085696	VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma	completed	Phase 2	66	Millennium Pharmaceuticals, Inc.INDUSTRY	1	Feb 11, 2008	clinicaltrials